HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Okumura Selected Research

Atsushi Okumura Research Topics

Disease

20Infections
01/2021 - 09/2007
17COVID-19
02/2022 - 01/2020
10Pneumonia (Pneumonitis)
01/2022 - 08/2014
4Vesicular Stomatitis
01/2022 - 09/2007
3Virus Diseases (Viral Diseases)
01/2021 - 03/2008
2Lung Diseases (Lung Disease)
02/2022 - 01/2022
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 04/2020
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2022
2Neoplasms (Cancer)
01/2016 - 01/2010
2Shock
10/2015 - 01/2010
2Ebola Hemorrhagic Fever
10/2015 - 01/2010
1Hyperplasia
01/2022
1Pulmonary Edema
01/2022
1Asymptomatic Infections
12/2021
1Crimean Hemorrhagic Fever
01/2021
1Animal Disease Models
12/2020
1Orthomyxoviridae Infections
02/2020
1Coronavirus Infections
01/2020
1Severe Acute Respiratory Syndrome
01/2020
1Protein-Losing Enteropathies (Protein-Losing Enteropathy)
05/2018
1Leukemia
01/2016
1Human Influenza (Influenza)
10/2015
1Lassa Fever (Fever, Lassa)
10/2015
1Mesothelioma
01/2010
1Malignant Mesothelioma
01/2010

Drug/Important Bio-Agent (IBA)

14VaccinesIBA
01/2022 - 09/2007
8Antiviral Agents (Antivirals)IBA
01/2022 - 03/2008
5Pharmaceutical PreparationsIBA
01/2021 - 01/2020
5Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2007
4molnupiravirIBA
02/2022 - 10/2020
4remdesivirIBA
01/2022 - 01/2020
4ChAdOx1 nCoV-19IBA
02/2021 - 05/2020
4CytokinesIBA
10/2015 - 01/2010
2NucleosidesIBA
02/2022 - 01/2022
2Viral AntigensIBA
02/2022 - 01/2022
2SARS-CoV-2 spike proteinIBA
01/2022 - 01/2021
2Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2021
2Neutralizing AntibodiesIBA
01/2021 - 01/2021
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2020 - 06/2020
2Ribavirin (Virazole)FDA LinkGeneric
10/2015 - 10/2013
2ChemokinesIBA
08/2014 - 10/2013
1FibrinIBA
01/2022
1RestonIBA
12/2021
1Synthetic Vaccines (Recombinant Vaccines)IBA
01/2021
1A-Form DNA (A-DNA)IBA
01/2021
1AntibodiesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Pasteurella multocida toxinIBA
02/2020
1ProdrugsIBA
01/2020
1NucleotidesIBA
01/2020
1Monoclonal AntibodiesIBA
01/2016
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2016
1EpitopesIBA
01/2016
1Neuraminidase (Sialidase)IBA
01/2016
1AntigensIBA
01/2016
1favipiravirIBA
10/2015
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2010
1eIF-2 Kinase (eIF 2 Kinase)IBA
01/2010
1Interferon-betaIBA
01/2010
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
01/2010
1Messenger RNA (mRNA)IBA
01/2010
1InterferonsIBA
01/2010
1UbiquitinIBA
03/2008
1UbiquitinsIBA
03/2008
1Matrix-MIBA
09/2007

Therapy/Procedure

4Therapeutics
04/2020 - 08/2014
1Aftercare (After-Treatment)
05/2018
1Immunotherapy
01/2016
1Euthanasia (Mercy Killing)
08/2014
1Oncolytic Virotherapy
01/2010